Hemodynamic effect of dobutamine in patients with severe heart failure

Area of Science:

• Cardiology
• Pharmacology

Background:

• Severe congestive heart failure (CHF) is characterized by impaired cardiac function.
• Low cardiac output is a critical determinant of prognosis in CHF.

Purpose of the Study:

• To evaluate the efficacy and safety of dobutamine in patients with severe congestive heart failure.
• To assess the effects of dobutamine on cardiac output, hemodynamics, and heart rate.

Main Methods:

• Dobutamine was infused at 10 mug/kg per min in 15 patients with severe CHF.
• Hemodynamic parameters including cardiac output, mean arterial pressure, heart rate, and pulmonary wedge pressure were monitored.
• A lower dose (5 mug/kg per min) was also tested in a subset of patients.

Main Results:

• Cardiac output increased significantly from 3.1 to 5.6 liters/min (P < 0.001).
• Pulmonary wedge pressure decreased significantly from 27.4 to 21.1 mm Hg (P < 0.001).
• Mean arterial pressure showed no significant change, and heart rate increased slightly (P < 0.02).
• The 5 mug/kg per min dose also increased cardiac output, but to a lesser extent.

Conclusions:

• Dobutamine is a potent inotropic agent with limited chronotropic and peripheral vascular effects.
• It demonstrates significant efficacy in improving cardiac output in severe CHF.
• Dobutamine warrants further investigation for the short-term management of low output heart failure.